ONWARD MEDICAL BV EO -12 (63E) — Working Capital to Net Assets Ratio
ONWARD MEDICAL BV EO -12 (63E) has a Working Capital to Net Assets ratio of 113.8% as of December 2025. Working capital of €62.98 Million (current assets of €74.08 Million minus current liabilities of €11.10 Million) is measured against net assets of €55.32 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of ONWARD MEDICAL BV EO -12 to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ONWARD MEDICAL BV EO -12 Working Capital to Net Assets (2021–2025)
This chart shows how ONWARD MEDICAL BV EO -12's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 113.8%, reflecting working capital of €62.98 Million against net assets of €55.32 Million EUR. See 63E days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for ONWARD MEDICAL BV EO -12 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ONWARD MEDICAL BV EO -12 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 63E market cap.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 113.8% | €62.98 Million | €55.32 Million | €74.08 Million | €11.10 Million | ▲ +0.8 pp |
| 2024 | 113.1% | €54.33 Million | €48.05 Million | €63.62 Million | €9.29 Million | ▼ -24.9 pp |
| 2023 | 138.0% | €24.74 Million | €17.93 Million | €31.42 Million | €6.68 Million | ▲ +31.7 pp |
| 2022 | 106.3% | €55.95 Million | €52.63 Million | €64.18 Million | €8.22 Million | ▲ +1.3 pp |
| 2021 | 105.0% | €86.84 Million | €82.68 Million | €92.39 Million | €5.54 Million | — |